These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33993682)

  • 1. [
    Loginova SY; Shсhukina VN; Savenko SV; Borisevich SV
    Vopr Virusol; 2021 May; 66(2):123-128. PubMed ID: 33993682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
    Schuhenn J; Meister TL; Todt D; Bracht T; Schork K; Billaud JN; Elsner C; Heinen N; Karakoese Z; Haid S; Kumar S; Brunotte L; Eisenacher M; Di Y; Lew J; Falzarano D; Chen J; Yuan Z; Pietschmann T; Wiegmann B; Uebner H; Taube C; Le-Trilling VTK; Trilling M; Krawczyk A; Ludwig S; Sitek B; Steinmann E; Dittmer U; Lavender KJ; Sutter K; Pfaender S
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
    Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
    Hao SR; Yan R; Zhang SY; Lian JS; Cai H; Zhang XL; Zheng L; Jia HY; Hu JH; Yu GD; Gu JQ; Ye CY; Jin CL; Lu YF; Xin JJ; Sheng JF; Yang YD
    J Zhejiang Univ Sci B; 2020 Aug.; 21(8):628-636. PubMed ID: 32748578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic of Recombinant Human Interferon Alpha-2b Nasal Drops and Effective Prophylaxis Against SARS-COV-2 Infection.
    Nodarse-Cuni H; Bravo O; Cañete R; Vázquez-Blomquist D; Quintana D; Aguilera-Barreto A; Guillen-Nieto G; Arteaga A; Morales I
    J Interferon Cytokine Res; 2024 Jun; 44(6):271-280. PubMed ID: 38597374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of SARS virus replication by human interferons.
    Dahl H; Linde A; Strannegård O
    Scand J Infect Dis; 2004; 36(11-12):829-31. PubMed ID: 15764169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2.
    Plante KS; Dwivedi V; Plante JA; Fernandez D; Mirchandani D; Bopp N; Aguilar PV; Park JG; Tamayo PP; Delgado J; Shivanna V; Torrelles JB; Martinez-Sobrido L; Matos R; Weaver SC; Sastry KJ; Newman RA
    Biomed Pharmacother; 2021 Jun; 138():111457. PubMed ID: 33721754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preventive and therapeutic effects of recombinant IFN-alpha2b nasal spray on SARS-CoV infection in Macaca mulata].
    Gao H; Zhang LL; Wei Q; Duan ZJ; Tu XM; Yu ZA; Deng W; Zhang LP; Bao LL; Zhang B; Tong W; Hou YD; Zhang BL; Huang L; Qin C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):207-10. PubMed ID: 16261198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
    Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-α2b induced anemia in severe coronavirus disease 2019 patients: a single centered, retrospective study.
    Li X; Liu T; Hai X; Li L
    Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):644-650. PubMed ID: 34698601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effects of human placenta hydrolysate (Laennec
    Kim EH; Kim YI; Jang SG; Im M; Jeong K; Choi YK; Han HJ
    J Microbiol; 2021 Nov; 59(11):1056-1062. PubMed ID: 34613605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study.
    Xu N; Pan J; Sun L; Zhou C; Huang S; Chen M; Zhang J; Zhu T; Li J; Zhang H; Gao Y
    Front Immunol; 2022; 13():967716. PubMed ID: 35990674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study.
    Pandit A; Bhalani N; Bhushan BLS; Koradia P; Gargiya S; Bhomia V; Kansagra K
    Int J Infect Dis; 2021 Apr; 105():516-521. PubMed ID: 33713817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2.
    Madonov PG; Svyatchenko VA; Legostaev SS; Kikhtenko NA; Kotlyarova AA; Oleinik LA; Baikalov GI
    Bull Exp Biol Med; 2021 Nov; 172(1):53-56. PubMed ID: 34791556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
    Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
    Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R
    Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro.
    Shi D; Chen K; Lu X; Cheng L; Weng T; Liu F; Wu N; Li L; Yao H
    Virol Sin; 2022 Apr; 37(2):295-298. PubMed ID: 35597770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Nikolaeva YV; Galochkina AV; Shtro AA; Berns SA
    Vopr Virusol; 2023 Mar; 68(1):26-36. PubMed ID: 36961233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.